These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2393260)
1. Concentrations of oral lomefloxacin in serum and bronchial mucosa. Baldwin DR; Honeybourne D; Andrews JM; Ashby JP; Wise R Antimicrob Agents Chemother; 1990 Jun; 34(6):1017-9. PubMed ID: 2393260 [TBL] [Abstract][Full Text] [Related]
2. Concentrations of temafloxacin in serum and bronchial mucosa. Baldwin DR; Wilkinson L; Andrews JM; Ashby JP; Wise R; Honeybourne D Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):432-4. PubMed ID: 2387297 [TBL] [Abstract][Full Text] [Related]
3. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration. Bergogne-Bérézin E; Muller-Serieys C; Kafé H Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076 [TBL] [Abstract][Full Text] [Related]
4. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration. Baldwin DR; Wise R; Andrews JM; Gill M; Honeybourne D Respir Med; 1993 Nov; 87(8):595-601. PubMed ID: 8290743 [TBL] [Abstract][Full Text] [Related]
5. The penetration of rufloxacin into sites of potential infection in the respiratory tract. Wise R; Andrews J; Imbimbo BP; Greaves I; Honeybourne D J Antimicrob Chemother; 1993 Dec; 32(6):861-6. PubMed ID: 8144426 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study. Cazzola M; Matera MG; Tufano MA; Catalanotti P; Polverino M; Cantoni V; Fici F; Sarlo F; Rossi F J Chemother; 2001 Aug; 13(4):407-12. PubMed ID: 11589484 [TBL] [Abstract][Full Text] [Related]
7. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa. Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D Eur Respir J; 1992 Apr; 5(4):471-6. PubMed ID: 1314193 [TBL] [Abstract][Full Text] [Related]
8. Penetration of lomefloxacin into human prostatic tissue. Leroy A; Humbert G; Fillastre JP; Grise P Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tissue penetration of orally administered lomefloxacin. Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181 [TBL] [Abstract][Full Text] [Related]
10. The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy. Honeybourne D; Andrews JM; Cunningham B; Jevons G; Wise R J Antimicrob Chemother; 1999 Jan; 43(1):153-5. PubMed ID: 10381116 [TBL] [Abstract][Full Text] [Related]
11. Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues. Wise R Am J Med; 1991 Dec; 91(6A):67S-70S. PubMed ID: 1662897 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of lomefloxacin in healthy volunteers: comparison of 400 milligrams once daily and 200 milligrams twice daily given orally for 5 days. Gros I; Carbon C Antimicrob Agents Chemother; 1990 Jan; 34(1):150-2. PubMed ID: 2327750 [TBL] [Abstract][Full Text] [Related]
13. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy. Andrews JM; Honeybourne D; Brenwald NP; Bannerjee D; Iredale M; Cunningham B; Wise R J Antimicrob Chemother; 1997 Jun; 39(6):797-802. PubMed ID: 9222050 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses. Morrison PJ; Mant TG; Norman GT; Robinson J; Kunka RL Antimicrob Agents Chemother; 1988 Oct; 32(10):1503-7. PubMed ID: 3214495 [TBL] [Abstract][Full Text] [Related]
15. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)]. Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259 [TBL] [Abstract][Full Text] [Related]
16. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses. Kavi J; Stone J; Andrews JM; Ashby JP; Wise R Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102 [TBL] [Abstract][Full Text] [Related]
17. Penetration of cefaclor into bronchial mucosa. Marlin GE; Nicholls AJ; Funnell GR; Bradbury R Thorax; 1984 Nov; 39(11):813-7. PubMed ID: 6505987 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers. Leigh DA; Harris C; Tait S; Walsh B; Hancock P J Antimicrob Chemother; 1991 May; 27(5):655-62. PubMed ID: 1885423 [TBL] [Abstract][Full Text] [Related]
19. Concentrations of lomefloxacin in radicular cyst and oral tissues following single or multiple oral administration. Akimoto Y; Mochizuki Y; Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Kaneko K; Kawana T; Fujii A J Nihon Univ Sch Dent; 1993 Dec; 35(4):267-75. PubMed ID: 8158288 [TBL] [Abstract][Full Text] [Related]
20. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections. Kovarik JM; Hoepelman AI; Smit JM; Sips PA; Rozenberg-Arska M; Glerum JH; Verhoef J Antimicrob Agents Chemother; 1992 Nov; 36(11):2458-61. PubMed ID: 1336948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]